Edgewise Therapeutics, Inc.

This is a very early study to check the safety of a new drug called EDG-7500 and see how it moves through the body. It will involve 24 healthy adults, both Japanese and Caucasian, who will receive single or multiple doses. The main goal is to understand the drug's safety profile …

This early study aims to understand how a new oral drug, EDG-7500, behaves in the body of people with different levels of liver function. It will compare blood levels and safety in 32 adults with mild or moderate liver impairment to those with normal liver function. The goal is t…